Results 51 to 60 of about 5,021,486 (245)

Efficacy of Ultrasound-guided Radiofrequency Ablation of Parathyroid Hyperplasia: Single Session vs. Two-Session for Effect on Hypocalcemia [PDF]

open access: yes, 2020
To evaluate safety and efficacy of one- vs. two-session radiofrequency ablation (RFA) of parathyroid hyperplasia for patients with secondary hyperparathyroidism (SHPT) and to compare the outcome of both methods on hypocalcemia.
He, Hong-Feng   +7 more
core   +1 more source

Study of PTH-FNAB of the Parathyroid Glands as a Method of Topical Diagnosis in Primary Hyperparathyroidism

open access: yesЭндокринная хирургия, 2014
The main difficulty of primary hyperparathyroidism in the surgical aspect, it is possible atypical location of the parathyroid glands and multiple nature of the lesion.
I V Kim, N S Kuznetsov, S N Kuznetsov
doaj   +1 more source

Mutations of the ret protooncogene in German multiple endocrine neoplasia families: Relation between genotype and phenotype. [PDF]

open access: yes, 1996
It has been suggested that not only the position but also the nature of the mutations of the ret protooncogene strongly correlate with the clinical manifestation of the multiple endocrine neoplasm type 2 (MEN 2) syndrome.
Deckart, H. F.   +15 more
core   +1 more source

Comparison of first- and second-line imaging diagnostics (ultrasound + scintigraphy and PET + 4DCT) in visualizing parathyroid glands in primary hyperparathyroidism including ectopic foci

open access: yesJournal of Education, Health and Sport
Introduction: Primary hyperparathyroidism is an endocrine disorder that causes disturbances in calcium and phosphorus metabolism in the human body.
Laura Loryś   +7 more
doaj   +1 more source

Primary Hyperparathyroidism: An Overview

open access: yesInternational Journal of Endocrinology, 2011
Primary hyperparathyroidism is a common condition that affects 0.3% of the general population. Primary and tertiary care specialists can encounter patients with primary hyperparathyroidism, and prompt recognition and treatment can greatly reduce ...
Jessica MacKenzie-Feder   +4 more
doaj   +1 more source

Genetic background influences tumour development in heterozygous Men1 knockout mice [PDF]

open access: yes, 2020
Multiple endocrine neoplasia type 1 (MEN1), an autosomal dominant disorder caused by MEN1 germline mutations, is characterised by parathyroid, pancreatic and pituitary tumours. MEN1 mutations also cause familial isolated primary hyperparathyroidism (FIHP)
Christie, Paul T.   +11 more
core   +2 more sources

Diagnosis and Management of Primary Hyperparathyroidism Across the Veterans Affairs Health Care System.

open access: yesJAMA Internal Medicine, 2019
Importance Untreated primary hyperparathyroidism impairs quality of life and incurs substantial costs. Parathyroidectomy is a low-risk, high-success, definitive intervention.
Elizabeth A. Alore   +7 more
semanticscholar   +1 more source

Aspects of surgical treatment of primary hyperparathyroidism

open access: yesActa Medica Leopoliensia, 2019
Aim. To evaluate the results of surgical treatment of patients with primary hyperparathyroidism. Material and methods. The work is based on retrospective and prospective analysis of the results of treatment among 81 patients with typical clinical ...
R.T. Kuzenko   +3 more
doaj   +1 more source

About A Rare Cause Of Primary Hyperparathyroidism [PDF]

open access: yes, 2011
Introduction: Primary hyperparathyroïdism is observed in 35 to 44 subjects/ 100000 persons. The increased production of parathyroid hormones is secondary to primary glandular modifications consisting mainly in adenomas.
Mona Mlika, Zidi-Moaffak Y , Lakhoua Y, Farah F, Kourda N, Ben Abdallah N, Zermani R, Baltagi-Ben Jilani S , Int J Cur Bio Med Sci.
core  

Romosozumab and Denosumab Combination Therapy After Denosumab in Postmenopausal Osteoporosis

open access: yesArthritis &Rheumatology, Accepted Article.
Background Transition from long‐term denosumab to PTH‐analogs or romosozumab might expose patients to the risk of the so‐called rebound phenomenon. Adding romosozumab to denosumab might represent an option in patients experiencing a fracture while on denosumab.
Giovanni Adami   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy